3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
12
Triple Negative Breast Neoplasms
5
Ovarian Neoplasms
4
Advanced Solid Tumors
4
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Neoplasms
3
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Ovarian Epithelial
2
mCRPC
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Recurrent Squamous Cell Lung Carcinoma
1
Recurrence
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Hereditary Sensory and Autonomic Neuropathies
1
Fanconi Anemia, Complementation Group D1
1
Endometrial Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Adenocarcinoma
1
Advanced Solid Tumor
1
Advanced Ovarian Cancer
1
Interventions
Dexamethasone
277
Lenalidomide
155
Bortezomib
152
Cyclophosphamide
115
Melphalan
107
Calcium Dobesilate
107
fludarabine phosphate
70
carfilzomib
61
pomalidomide
55
Peripheral Blood Stem Cell Transplantation
53
Whole-Body Irradiation
52
Mycophenolic Acid
52
Granulocyte Colony-Stimulating Factor
52
Filgrastim
52
daratumumab
46
fludarabine
43
Tacrolimus
41
ixazomib
40
Busulfan
40
Thalidomide
36
Cyclosporine
32
dexamethasone acetate
26
Stem Cell Transplantation
26
Antilymphocyte Serum
25
dexamethasone 21-phosphate
22
plerixafor
20
auricularum
20
belantamab mafodotin
19
Prednisone
19
Etoposide
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Multiple Myeloma
×
talazoparib
×
Clear all
No trials found.